1. Home
  2. WST vs ARES Comparison

WST vs ARES Comparison

Compare WST & ARES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • ARES
  • Stock Information
  • Founded
  • WST 1923
  • ARES 1997
  • Country
  • WST United States
  • ARES United States
  • Employees
  • WST N/A
  • ARES N/A
  • Industry
  • WST Medical/Dental Instruments
  • ARES Investment Managers
  • Sector
  • WST Health Care
  • ARES Finance
  • Exchange
  • WST Nasdaq
  • ARES Nasdaq
  • Market Cap
  • WST 23.2B
  • ARES 35.7B
  • IPO Year
  • WST N/A
  • ARES 2014
  • Fundamental
  • Price
  • WST $332.77
  • ARES $181.06
  • Analyst Decision
  • WST Strong Buy
  • ARES Buy
  • Analyst Count
  • WST 5
  • ARES 14
  • Target Price
  • WST $437.75
  • ARES $166.00
  • AVG Volume (30 Days)
  • WST 494.1K
  • ARES 1.2M
  • Earning Date
  • WST 02-13-2025
  • ARES 02-06-2025
  • Dividend Yield
  • WST 0.25%
  • ARES 2.06%
  • EPS Growth
  • WST N/A
  • ARES 0.39
  • EPS
  • WST 6.74
  • ARES 2.19
  • Revenue
  • WST $2,876,400,000.00
  • ARES $3,679,765,000.00
  • Revenue This Year
  • WST N/A
  • ARES $0.31
  • Revenue Next Year
  • WST $6.08
  • ARES $34.12
  • P/E Ratio
  • WST $49.37
  • ARES $82.86
  • Revenue Growth
  • WST N/A
  • ARES 4.67
  • 52 Week Low
  • WST $265.00
  • ARES $112.83
  • 52 Week High
  • WST $413.70
  • ARES $185.06
  • Technical
  • Relative Strength Index (RSI)
  • WST 58.00
  • ARES 57.80
  • Support Level
  • WST $325.33
  • ARES $169.01
  • Resistance Level
  • WST $335.53
  • ARES $185.06
  • Average True Range (ATR)
  • WST 7.96
  • ARES 4.73
  • MACD
  • WST 0.32
  • ARES -0.41
  • Stochastic Oscillator
  • WST 78.28
  • ARES 75.08

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About ARES Ares Management Corporation

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets and Secondaries Group. Its Credit Group generates maximum revenue, and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate and infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure and credit.

Share on Social Networks: